Delivery Order SPE2DB20D3103-SPE2DB25FP6S6
Award Date 7/28/25
Potential Completion Date 8/18/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $37,180.20 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 11.7 mL on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award under a larger vehicle, reflecting AmerisourceBergen's established...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,436.04 firm fixed price delivery order is for 1,400 mg-23,400 11.7 ml units of the medication Rituxan Hycela. The contract has a completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a $14,818 delivery order to Amerisourcebergen Drug Corporation for RITUXAN HYCELA, a monoclonal antibody used to treat certain types of cancer and autoimmune disorders. The firm fixed price order is for delivery of 1,400 mg doses to a facility in Conshohocken, Pennsylvania between June and July 2023. Amerisourcebergen will fulfill the order as the prime contractor from its Corporate Office Division. No additional details were provided regarding subcontractors...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $29,254.08 firm fixed price contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug RITUXAN HYCELA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,718.02, is for the delivery of Rituxan Hycela 1,400 mg-23,400 11.7 ml. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 21, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price delivery order is for RITUXAN HYCELA 1,400 MG-23,400 11.7ML, with a period of performance through July 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $14,818.40 to Amerisourcebergen Drug Corporation for 1,400 mg-23,400 11.7ml doses of rituximab and hyaluronidase human injection. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a period spanning September 26, 2023 through October 18, 2023. The delivery order was issued against an unidentified indefinite-delivery/indefinite-quantity contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.04, is for the delivery of Rituxan Hycela, a medication used for the treatment of certain types of cancer and autoimmune disorders. The contract is a firm-fixed-price, non-set-aside delivery order with a performance period ending on May 19, 2025. AmerisourceBergen Drug Corp,...
- This federal contract award is for the delivery of Rituxan Hycela, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,334.26 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,308.12, is for the delivery of RITUXAN HYCELA 1,400 MG-23,400 11.7ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...